World's Best Scientists 2026 revealed!
Joseph B. Muhlestein

Joseph B. Muhlestein

D-Index & Metrics

Medicine

D-Index
84
Citations
28444
World Ranking
15007
National Ranking
7586

Joseph B. Muhlestein publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joseph B. Muhlestein sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 682 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joseph B. Muhlestein D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph B. Muhlestein sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Joseph B. Muhlestein is affiliated with the University of Utah in the United States. Their research primarily spans the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine, where they have contributed to 54 publications. Other notable subfields include Surgery, Physiology, Radiology, Nuclear Medicine and Imaging, and Endocrinology, Diabetes and Metabolism.

The research topics covered by Muhlestein reflect a concentrated interest in cardiovascular health and metabolic processes. Key topics include:

  • Dietary Effects on Health
  • Cardiac Imaging and Diagnostics
  • Lipoproteins and Cardiovascular Health
  • Diet and metabolism studies
  • Heart Failure Treatment and Management
  • Blood Pressure and Hypertension Studies
  • Atrial Fibrillation Management and Outcomes

Muhlestein has coauthored numerous papers with several frequent collaborators. Notable coauthors include Kirk U. Knowlton, Jeffrey L. Anderson, Heidi T. May, Viet T. Le, and Tami L. Bair, each coauthoring dozens of papers with Muhlestein.

They have published extensively in several high-profile academic journals. Frequent publication venues are:

  • Circulation
  • Journal of the American College of Cardiology
  • American Heart Journal
  • Journal of Clinical Medicine
  • Frontiers in Cardiovascular Medicine

Recent papers authored or coauthored by Joseph B. Muhlestein include:

  • Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial (2020, European Heart Journal)
  • Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results (2020, Cardiovascular Research)
  • Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse (2022, European Heart Journal)
  • International consensus on fasting terminology (2024, Cell Metabolism)
  • Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial (2021, American Heart Journal)

Best Publications

  • Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

    Heribert Schunkert;Inke R. König;Sekar Kathiresan;Muredach P. Reilly

  • Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk

    Benjamin D. Horne;Jeffrey L. Anderson;Jeffrey L. Anderson;Jerry M. John;Jerry M. John;Aaron Weaver;Aaron Weaver

  • Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation

    Jeffrey L. Anderson;Benjamin D. Horne;Scott M. Stevens;Amanda S. Grove

  • Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population

    Jeffrey L. Anderson;Jeffrey L. Anderson;Heidi T. May;Benjamin D. Horne;Benjamin D. Horne;Tami L. Bair

  • Ischemic Heart Disease Events Triggered by Short-Term Exposure to Fine Particulate Air Pollution

    C. Arden Pope;Joseph B. Muhlestein;Heidi T. May;Dale G. Renlund

  • Infection With Chlamydia pneumoniae Accelerates the Development of Atherosclerosis and Treatment With Azithromycin Prevents It in a Rabbit Model

    Joseph B. Muhlestein;Jeffrey L. Anderson;Elizabeth H. Hammond;Liping Zhao

  • Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease

    Joseph B. Muhlestein;Elizabeth H. Hammond;John F. Carlquist;Ellen Radicke

  • Azithromycin for the Secondary Prevention of Coronary Events

    J. Thomas Grayston;Richard A. Kronmal;Lisa A. Jackson;Alfred F. Parisi

  • An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense : Results of a randomized study (ROMIO)

    Miguel A. Gomez;Jeffrey L. Anderson;Labros A. Karagounis;Joseph B. Muhlestein

  • Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.

    Jeffrey L Anderson;John F Carlquist;John F Carlquist;Joseph B Muhlestein;Joseph B Muhlestein;Benjamin D Horne;Benjamin D Horne

  • Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease and Serological Evidence for Chlamydia pneumoniae Infection The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) Study

    Jeffrey L. Anderson;Joseph B. Muhlestein;John Carlquist;Ann Allen

  • Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.

    Christopher M. O'Connor;Michael W. Dunne;Marc A. Pfeffer;Joseph B. Muhlestein

  • Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.

    T. Jared Bunch;J. Peter Weiss;Brian G. Crandall;Heidi T. May

  • Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

    Joseph B. Muhlestein;Joseph B. Muhlestein;Donald L. Lappé;Donald L. Lappé;Joao A. C. Lima;Boaz D. Rosen

  • Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death

    J Zhu;F J Nieto;B D Horne;J L Anderson

  • Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease

    Jeffrey L. Anderson;Joseph B. Muhlestein;Benjamin D. Horne;John F. Carlquist

  • Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.

    Matthew J Budoff;Deepak L Bhatt;April Kinninger;Suvasini Lakshmanan

  • Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease

    Adam S. Butterworth;Peter S. Braund;Martin Farrall;Robert J. Hardwick

  • C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.

    James S Zebrack;Joseph B Muhlestein;Benjamin D Horne;Jeffrey L Anderson

  • Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease Primary Clinical Results of the ACADEMIC Study

    Joseph B. Muhlestein;Jeffrey L. Anderson;John F. Carlquist;Kirti Salunkhe

Frequent Co-Authors

Benjamin D. Horne
Benjamin D. Horne Stanford University
Jeffrey L. Anderson
Jeffrey L. Anderson University of Utah
Dale G. Renlund
Dale G. Renlund University of Utah
Nicola J. Camp
Nicola J. Camp University of Utah
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Timothy D. Henry
Timothy D. Henry Cedars-Sinai Medical Center
Samir R. Kapadia
Samir R. Kapadia Cleveland Clinic
Sunil V. Rao
Sunil V. Rao Duke University School of Medicine
William S. Weintraub
William S. Weintraub Georgetown University
J. Wouter Jukema
J. Wouter Jukema Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA isn’t limited to traditional medical school. There are many online degrees and career pathways in healthcare, especially for those interested in nursing and advanced practice roles. Flexibility, cost, and entry requirements vary—so it’s important to find the option that fits your life and career goals.

For those with a Bachelor of Science in Nursing and looking to reach leadership positions, cheapest dnp programs offer a pathway to the highest level of clinical expertise without heavy financial burden. If you’re a registered nurse wanting to advance your credentials, there are affordable rn to bsn programs available online, designed to complement your work schedule.

Individuals without a nursing background can pursue healthcare by enrolling in online msn programs for non nurses, helping them transition quickly into nursing roles. For aspiring nurses concerned about the competitive nature of admissions, some direct entry nursing programs are more accessible, allowing students to start their journey in medicine sooner.

Best Scientists Citing Joseph B. Muhlestein

Trending Scientists

Recently Published Articles